You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Mass. Movers

Constipation drug wins European approval

Cambridge-based Ironwood Pharmaceuticals Inc.’s drug to treat irritable bowel syndrome with constipation has won marketing approval in Europe. Linaclotide, for adults, will be launched in Europe next year as Constella. The drug received US approval in August. Ironwood will sell the drug in the United States with a marketing partner, Forest Laboratories, under the brand name Linzess. A Ladenburg Thalmann analyst estimated Constella could bring in revenue of $189 million in 2018.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week